Home Your basket
• Treatment and rehabilitat...
   Price 10.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Mast cells in chronic inf...
   Price 10.50 €
• Predictive factors for su...
   Price 15.00 €
• Eye rings: Morphological ...
   Price 10.50 €
• The eye movement autophon...
   Price 14.00 €
• Laryngeal dystonia and as...
   Price 8.50 €
• Cochlear implantation in ...
   Price 5.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Occult otologic fistulas ...
   Price 5.50 €
• Virtual audiovisual talki...
   Price 10.50 €
• A non-linear model of lar...
   Price 10.50 €
• Multi-factorial analysis ...
   Price 10.50 €
• Tuberculous acute mastoid...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Bilateral latero-pontine ...
   Price 5.50 €
• Static management of lago...
   Price 10.50 €
• Post-traumatic otoscleros...
   Price 8.50 €
• Prosthetics gains and sat...
   Price 12.50 €
• The benefit of phoniatric...
   Price 8.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• The monaural pseudo-stere...
   Price 8.50 €
• Migrating hypopharyngeal ...
   Price 5.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• Velo-pharyngeal incompete...
   Price 14.00 €
• What we don’t know about ...
   Price 12.50 €
• Personal experience about...
   Price 10.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 10.50 €
• Reports to the General As...
   Price 10.50 €
• Functional comparison of ...
   Price 14.00 €
• Evolution of facial nerve...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Study of the predictive v...
   Price 10.50 €
• F0 characteristics in Par...
   Price 12.00 €
• Post intubation collected...
   Price 8.50 €
• Modified butterfly cartil...
   Price 10.50 €

Total Order 367.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE